Table 3

Association of major cardiac events during pregnancy with demographic, clinical and obstetric characteristics

Overall (n=39)Major cardiac events (n=7)No major events (n=32)p Value major event vs none
VA (n=5)HF (n=2)
Maternal characteristics
 Age (at conception; mean, years)31.3±3.631.7±1.934.4±4.731.0±3.70.34
 Nationality (% American)31 (79)5 (100)1 (50)25 (78)1.0
 Primigravida (%)14 (36)2 (40)2 (100)10 (31)0.23
 Proband (%)21 (54)5 (100)1 (50)15 (47)0.10
 Mutation carrier (%)25 (64)3 (60)2 (100)20 (63)0.65
ARVD/C history prepregnancy
 Recognised disease (%)29 (74)2 (40)2 (100)25 (78)0.34
 ICD implanted (%)25 (64)2 (40)2 (100)21 (66)0.69
Cardiac characteristics prepregnancy
 Sustained VT/ICD shock (%, VA)9 (23)0 (0)1 (50)8 (25)1.0
 Major structural RV disease by 2010 TFC* (%)11/37 (30)1 (20)2 (100)8/30 (27)*0.40
 LV ejection fraction <55% (%)2 (5)0 (0)1 (50)1 (3)0.33
 Heart failure ≥ Class C (%, HF)0 (0)0 (0)0 (0)0(0)1.0
Obstetric outcomes
 Liveborn (%)39 (100)5 (100)2 (100)32 (100)1.0
 Delivery (% vaginal)28 (72)3 (60)1 (50)24 (75)0.38
 Birth weight (mean, kg)†3.4±0.63.0±0.42.9±1.33.5±0.6†0.047
 Full-term delivery (% ≥37 weeks)37 (95)5 (100)2 (100)30 (94)1.0
  • *RV structure prepregnancy was unavailable in two cases.

  • †Birth weight was unavailable for one full-term healthy infant.

  • ARVD/C, arrhythmogenic right ventricular dysplasia/cardiomyopathy; HF, heart failure ≥ Class C19; ICD, implantable cardioverter defibrillator; LV, left ventricular; RV, right ventricular; TFC, 2010 Task Force Criteria16; VA, sustained ventricular arrhythmia or appropriate ICD therapy; VT, ventricular tachycardia.